Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advanced Search
[FR Doc 02-32517] 51. Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 4981210. Send written
Published: 2002-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 02-32511] 52. Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting:
Name: Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH).
Time and Date: 8 a.m.5 p.m.,
Published: 2002-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 02-32342] 53. Implantation or Injectable Dosage Form New Animal Drugs; Trenbolone and
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Ivy Laboratories, Division of Ivy Animal Health, Inc. The ANADA provides for subcutaneous use of an implant containing trenbolone acetate and estradiol for increased rate of weight gain
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 02-32354] 54. National Institute of Nursing Research; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Nursing Research.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance,
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32344] 55. Trimethobenzamide Hydrochloride Injection and Capsules; Drug Efficacy Study
The Food and Drug Administration (FDA) announces the resolution of issues concerning trimethobenzamide hydrochloride injection and capsules. This notice announces the approval of a supplemental new drug application (NDA) for Tigan (trimethobenzamide hydrochloride) Capsules, 300 milligrams (mg), and states that continued marketing of unapproved
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 02-32356] 56. National Institute on Alcohol Abuse and Alcoholism; Notice of Closed
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32277] 57. Gastroenterology and Urology Devices Panel of the Medical Devices Advisory
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee.
General Function of the Committee: To provide advice and recommendations to
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 02-32357] 58. National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6). title 5 U.S.C., as amended. The grant applications and the discussions
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32351] 59. National Library of Medicine; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice
[[Page 78488]]
is hereby given of the following meeting.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32350] 60. Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by agencies of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32362] 61. National Library of Medicine; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the Board of Regents of the National Library of Medicine.
The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32360] 62. National Center for Complementary and Alternative Medicine; Notice of
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM).
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32347] 63. Prospective Grant of Exclusive License: Methods and Compositions for the
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR
[[Page 78489]]
404.7(a)(1)(i), that the National Institutes of Health, Department of
Health and Human Services, is contemplating the grant of an exclusive
license to practice the invention embodied in U.S. provisional patent
application 60/351,386 (DHHS ref. no. E0532002/0US01) filed
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32355] 64. National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council.
[[Page 78484]]
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32332] 65. Agency Information Collection Activities: Submission for OMB Review; Comment
Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (301) 4437978.
Prevention
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration
[FR Doc 02-32358] 66. National Institutes of Allergy and Infectious Diseases; Notice of Closed
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32304] 67. Community Mental Health Services Performance Partnership
Section 1949 of the Public Health Service Act as amended by
Pub. L. 106310 requires the Secretary of Health and Human Services to
submit a plan to Congress detailing how the Secretary intends to change
the current Community Mental Health Services (CMHS) Block Grant into a
performance partnership. The plan, by statute, must include the following:
A
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration
[FR Doc 02-32359] 68. National Institute of Allergy and Infectious Diseases; Notice of Closed
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32305] 69. Community Mental Health Services Performance Partnership
Section 1949 of the Public Health Service Act as amended by Public Law 106310 requires the Secretary of Health and Human Services to submit a plan to Congress detailing how the Secretary intends to change the current Community Mental Health Services (CMHS) Block Grant into a performance partnership. The plan, by statute, must include the
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration
[FR Doc 02-32341] 70. Oral Dosage Form New Animal Drugs; Florfenicol
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by ScheringPlough Animal Health Corp. The NADA provides for use of a florfenicol concentrate solution to make medicated drinking water for administration to swine for the treatment of respiratory disease.
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 02-32340] 71. Statement of Organization, Functions, and Delegations of Authority
Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 6777276, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 67 FR 6247577, dated October 07, 2002) is amended to
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 02-32364] 72. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 02-32367] 73. Proposed Information Collection Activity; Comment Request
Proposed Projects:
Title: Biennial Child Care Report for High Performance Bonus.
OMB No.: ACF900.
Description: The Personal Responsibility and Work Opportunity Reconciliation Act of 1996, Public Law 104193, established the Temporary Assistance for Needy Families (TANF) program under title IVA of the Social Security Act (the Act), 42
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Children and Families Administration
[FR Doc 02-32343] 74. Oral Dosage Form New Animal Drugs; Lincomycin Hydrochloride Soluble Powder
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Alpharma, Inc. The supplemental ANADA provides for reducing the preslaughter withdrawal time to zero days for use of lincomycin soluble powder in medicated drinking water for
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 02-32368] 75. Proposed Information Collection Activity; Comment Request
Proposed Projects:
Title: Evaluation of Independent Living Program Funded Under the Chafee Foster Care Independence Program.
OMB No.: New Collection.
Description: The Foster Care Independence Act of 1999 (Public Law 106169) mandates evaluations of promising Independent Living Program administered by state and local child welfare
Published: 2002-12-24 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Children and Families Administration
Years: 20002001200220032004200520062007200820092010